- Home
- IBO vs NAII Comparison
IBO vs NAII Comparison
Compare IBO & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBO
- NAII
- Stock Information
- Founded
- IBO 2018
- NAII 1980
- Country
- IBO United States
- NAII United States
- Employees
- IBO N/A
- NAII N/A
- Industry
- IBO
- NAII Medicinal Chemicals and Botanical Products
- Sector
- IBO
- NAII Health Care
- Exchange
- IBO NYSE
- NAII Nasdaq
- Market Cap
- IBO 22.1M
- NAII 26.0M
- IPO Year
- IBO 2024
- NAII 1987
- Fundamental
- Price
- IBO $2.12
- NAII $4.05
- Analyst Decision
- IBO
- NAII
- Analyst Count
- IBO 0
- NAII 0
- Target Price
- IBO N/A
- NAII N/A
- AVG Volume (30 Days)
- IBO 23.0K
- NAII 4.9K
- Earning Date
- IBO 03-04-2025
- NAII 02-14-2025
- Dividend Yield
- IBO N/A
- NAII N/A
- EPS Growth
- IBO N/A
- NAII N/A
- EPS
- IBO 0.01
- NAII N/A
- Revenue
- IBO N/A
- NAII $121,853,000.00
- Revenue This Year
- IBO N/A
- NAII N/A
- Revenue Next Year
- IBO N/A
- NAII N/A
- P/E Ratio
- IBO $175.47
- NAII N/A
- Revenue Growth
- IBO N/A
- NAII N/A
- 52 Week Low
- IBO $1.16
- NAII $4.02
- 52 Week High
- IBO $3.25
- NAII $7.26
- Technical
- Relative Strength Index (RSI)
- IBO N/A
- NAII 36.48
- Support Level
- IBO N/A
- NAII $4.08
- Resistance Level
- IBO N/A
- NAII $4.19
- Average True Range (ATR)
- IBO 0.00
- NAII 0.11
- MACD
- IBO 0.00
- NAII -0.01
- Stochastic Oscillator
- IBO 0.00
- NAII 8.76
About IBO IMPACT BIOMEDICAL INC
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The Company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza.
About NAII Natural Alternatives International Inc.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.